6-甲氧基吲哚-3-甲醛 | 70555-46-3

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 6-甲氧基吲哚-3-甲醛
• 中文别名: 6-甲氧基-1H-吲哚-3-甲醛
• 英文名称: 6-methoxy-1H-indole-3-carbaldehyde
• 英文别名: 6-methoxyindole-3-carbaldehyde；6-methoxyindole-3-carboxaldehyde；6-methoxy indole-3-aldehyde；6-methoxy-1H-indole-3-carboxaldehyde
• CAS: 70555-46-3
• 化学式: C₁₀H₉NO₂
• mdl: MFCD03848058
• 分子量: 175.187
• InChiKey: JTEFJNIWWXTBMP-UHFFFAOYSA-N

物化性质

• 熔点：
  185 °C
• 沸点：
  375.2±22.0 °C(Predicted)
• 密度：
  1.273±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险品标志：
  Xi
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  温度：2-8℃，保持惰性气体氛围。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Methoxy-1H-indole-3-carbaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H319: Causes serious eye irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Methoxy-1H-indole-3-carbaldehyde
CAS number: 70555-46-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H9NO2
Molecular weight: 175.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-甲氧基吲哚-3-甲醛 在 potassium carbonate 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 生成
  参考文献：
  名称：

  泛黄霉素的合成研究I.（±）-12-deoxy-12-epifumitremorgin B的合成

  摘要：

  制备含有氧化异戊烯基部分的二酮哌嗪衍生物5。5的醛醇产物和官能化的吲哚-3-醛7是四种立体异构体的混合物，它们以良好的产率被转化为单个的四氢-β-咔啉衍生物12-脱氧-12-表铁-mor草烷B（2）。

  DOI：

  10.1016/s0040-4039(00)84537-2
• 作为产物：
  描述：

  6-甲氧基-1H-吲哚-2-羧酸甲酯 在 sodium hydroxide 、 铜 、 三氯氧磷 作用下， 以 喹啉 为溶剂， 反应 2.5h， 生成 6-甲氧基吲哚-3-甲醛
  参考文献：
  名称：

  进入 6-甲氧基-D(+)-色氨酸。1-苯磺酰基-6-甲氧基-D(+)-色氨酸乙酯的立体有择合成

  摘要：

  摘要 采用 Moody azide/Schollkopf 手性辅助方案合成光学活性环-A 甲氧基化吲哚生物碱的策略已成功制备 1-苯磺酰基-6-甲氧基-D(+)-色氨酸乙酯 16。该氨基酯是通过对映特异性 Pictet-Spengler 反应合成 Alstonia 双吲哚生物碱（包括 macralstonine 2）所必需的。

  DOI：

  10.1080/00397919208021343

文献信息

• [EN] 2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS<br/>[FR] DÉRIVÉS DE 2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE ET COMPOSÉS CORRESPONDANTS UTILISÉS EN TANQUE QUE AGONISTES DU RÉCEPTEUR D'HYDROCARBURE ARYLE (AHR) UTILISÉS POUR LE TRAITEMENT DE, P.EX., DE L'ANGIOGENÈSE IMPLIQUÉE OU DE TROUBLES INFLAMMATOIRES
  申请人：IKENA ONCOLOGY INC

  公开号：WO2021127302A1

  公开（公告）日：2021-06-24

  2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).

  2-(1H-吲哚-3-甲酰基)-噻唑-4-羧酰胺衍生物及相应的咪唑、噁唑和噻吩衍生物以及相关化合物作为芳香烃受体（AHR）激动剂，用于治疗涉及血管生成的疾病，例如视网膜病变、银屑病、类风湿性关节炎、肥胖和癌症，或炎症性疾病。本说明书揭示了示例化合物的合成和表征以及其药理数据（例如第27至32页和59至219页；示例1至8；化合物1-1至1-97；表1-a、2和3）。
• Novel and potent human and rat β3-Adrenergic receptor agonists containing substituted 3-indolylalkylamines
  作者：Hiroshi Harada、Yoshimi Hirokawa、Kenji Suzuki、Yoichi Hiyama、Mayumi Oue、Hitoshi Kawashima、Naoyuki Yoshida、Yasuji Furutani、Shiro Kato

  DOI：10.1016/s0960-894x(03)00073-8

  日期：2003.4

  A novel series of 2-(3-indolyl)alkylamino-1-(3-chlorophenyl)ethanols was prepared and evaluated for in vitro ability to stimulate cAMP production in Chinese hamster ovary cells expressing cloned human beta(3)-AR. The optically active 30a was found to be the most potent and selective human beta(3)-AR agonist in this series with an EC(50) value of 0.062nM. In addition, 30a selectivity for human beta(3)-AR

  制备了一系列新型的2-（3-吲哚基）烷基氨基-1-（3-氯苯基）乙醇，并评估了体外刺激表达克隆的人β（3）-AR的中国仓鼠卵巢细胞中cAMP产生的能力。发现旋光性30a是该系列中最有效和选择性最强的人类β（3）-AR激动剂，EC（50）值为0.062nM。此外，对人beta（3）-AR的30a选择性分别为对人beta（2）-AR和beta（1）-AR的210倍和103倍。此外，30a对大鼠beta（3）-AR表现出强大的激动作用。
• Visible-Light-Induced Trifluoromethylation of Isonitrile-Substituted Indole Derivatives: Access to 1-(Trifluoromethyl)-4,9-dihydro-3<i>H</i>-pyrido[3,4-b]indole and<i>β</i>-Carboline Derivatives
  作者：Jiaxin Liu、Longhai Li、Liuzhu Yu、Lisha Tang、Qin Chen、Min Shi

  DOI：10.1002/adsc.201800568

  日期：2018.8.6

  visible‐light‐induced trifluoromethylation of isonitrile‐substituted indole derivatives has been developed from the reaction of isonitrile‐substituted indoles with Togni II reagent, affording 1‐(trifluoromethyl)‐4,9‐dihydro‐3H‐pyrido[3,4‐b]indoles in moderate to good yields. The further transformations to β‐carboline derivatives and a harmacine derivative have been performed, demonstrating the potential synthetic

  的可见光诱导的异腈基取代的吲哚衍生物的三氟甲基化已经从与TOGNI II试剂异腈取代的吲哚的反应研制，得到1-（三氟甲基）-4,9-二氢-3- ħ -吡啶并[3,4 ‐b]吲哚产量中等至良好。已经进行了向β-咔啉衍生物和harmacine衍生物的进一步转化，证明了该方法的潜在合成效用。一项初步的生物学研究表明，含有CF 3的harmine类似物可显着刺激胰高血糖素样肽1（GLP-1）的分泌，表明糖尿病的治疗有所改善。
• Novel Affinity Ligands for Chromatography Using Combinatorial Chemistry
  作者：Tor Regberg、Charlotta Lindquist、Ake Pilotti、Christel Ellstrom、Lars Fagerstam、Ann Eckersten、Yasuro Shinohara、Steven L. Gallion、Joseph C. Hogan

  DOI：10.2174/138620711795222482

  日期：2011.5.1

  Spatially addressable combinatorial libraries were synthesized by solution phase chemistry and screened for binding to human serum albumin. Members of arylidene diamide libraries were among the best hits found, having submicromolar binding affinities. The results were analyzed by the frequency with which particular substituents appeared among the most potent compounds. After immobilization of the ligands either through the oxazolone or the amine substituent, characterization by surface plasmon resonance showed that ibuprofen affected the binding kinetics, but phenylbutazone did not. It is therefore likely that these compounds bind to Site 2 in sub domain IIIA of human serum albumin (HSA).

  通过溶液相化学合成了空间可寻址的组合库，并对其与人体血清白蛋白的结合能力进行了筛选。在发现的优秀结合分子中，有一类是芳亚基二酰胺类化合物，它们具有亚微摩尔级别的结合亲和力。通过对这些最强效化合物中特定取代基出现的频率进行分析，得出了结果。通过醛酮或胺取代基将配体固定化后，利用表面等离子体共振技术进行表征，结果显示布洛芬影响了结合动力学，而保泰松则没有。因此，这些化合物很可能结合在人血清白蛋白（HSA）亚域IIIA的第2位点上。
• 5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)alkancarboxylic Acids as Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies
  作者：Volodymyr Horishny、Victor Kartsev、Athina Geronikaki、Vasyl Matiychuk、Anthi Petrou、Jasmina Glamoclija、Ana Ciric、Marina Sokovic

  DOI：10.3390/molecules25081964

  日期：——

  inhibit biofilm formation 2- to 4-times more than both reference drugs. Compounds were evaluated also for their antifungal activity against eight species. The evaluation revealed that all compounds exhibited antifungal activity better than the reference drugs bifonazole and ketoconazole. Molecular docking studies on antibacterial and antifungal targets were performed in order to elucidate the mechanism

  背景：传染病象征着全球对公共卫生安全造成的后果性压力，并对世界各地的社会经济稳定产生影响。对当前抗菌治疗的耐药性日益增加，迫切需要发现和开发具有不同作用模式的感染治疗新实体，这些实体可以同时针对敏感菌株和耐药菌株。方法：使用有机合成的经典方法合成化合物。结果：所有 20 种合成化合物均显示出对 8 种革兰氏阳性和革兰氏阴性细菌的抗菌活性。应该提到的是，所有化合物对所有测试的细菌都表现出比氨苄青霉素更好的抗菌效力。此外，18 种化合物似乎比链霉素更有效地对抗金黄色葡萄球菌、阴沟肠杆菌、铜绿假单胞菌、单核细胞增生李斯特菌和大肠杆菌。三种最活跃的化合物 4h、5b 和 5g 似乎比氨苄青霉素更有效地对抗 MRSA，而链霉素没有显示任何杀菌活性。与氨苄青霉素相比，所有三种化合物对铜绿假单胞菌和大肠杆菌的耐药菌株也显示出更好的活性。此外，所有化合物都能够比两种参考药物抑制生物膜形成多 2 到 4 倍